(Q33415066)

English

Blood stage malaria vaccine eliciting high antigen-specific antibody concentrations confers no protection to young children in Western Kenya

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

26 July 2017

Blood stage malaria vaccine eliciting high antigen-specific antibody concentrations confers no protection to young children in Western Kenya (English)

1 reference

Europe PubMed Central

26 July 2017

0 references

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

malaria vaccine

1 reference

based on heuristic

inferred from title

10

object named as

Janet Wittes

1 reference

Europe PubMed Central

26 July 2017

W Ripley Ballou

21

object named as

W Ripley Ballou

1 reference

Europe PubMed Central

26 July 2017

Christian F Ockenhouse

19

object named as

Christian F Ockenhouse

1 reference

Europe PubMed Central

26 July 2017

23

object named as

Evelina Angov

1 reference

Europe PubMed Central

26 July 2017

D. Gray Heppner

26

object named as

D Gray Heppner

1 reference

Europe PubMed Central

26 July 2017

Denise M. McKinney

3

object named as

Denise McKinney

1 reference

Europe PubMed Central

26 July 2017

5

object named as

Joram Siangla

1 reference

Europe PubMed Central

26 July 2017

Kathryn M Tucker

7

object named as

Kathryn Tucker

1 reference

Europe PubMed Central

26 July 2017

John N Waitumbi

8

object named as

John N Waitumbi

1 reference

Europe PubMed Central

26 July 2017

9

object named as

Carter Diggs

1 reference

Europe PubMed Central

26 July 2017

Elissa M Malkin

11

object named as

Elissa Malkin

1 reference

Europe PubMed Central

26 July 2017

12

object named as

Amanda Leach

1 reference

Europe PubMed Central

26 July 2017

Lorraine A Soisson

13

object named as

Lorraine A Soisson

1 reference

Europe PubMed Central

26 July 2017

Jessica B Milman

14

object named as

Jessica B Milman

1 reference

Europe PubMed Central

26 July 2017

15

object named as

Lucas Otieno

1 reference

Europe PubMed Central

26 July 2017

MSP-1 Malaria Vaccine Working Group

28

object named as

MSP-1 Malaria Vaccine Working Group

1 reference

Europe PubMed Central

26 July 2017

author name string

Bernhards R Ogutu

1

1 reference

Europe PubMed Central

26 July 2017

Odika J Apollo

2

1 reference

Europe PubMed Central

26 July 2017

Willis Okoth

4

1 reference

Europe PubMed Central

26 July 2017

Filip Dubovsky

6

1 reference

Europe PubMed Central

26 July 2017

Carolyn A Holland

16

1 reference

Europe PubMed Central

26 July 2017

Mark Polhemus

17

1 reference

Europe PubMed Central

26 July 2017

Shon A Remich

18

1 reference

Europe PubMed Central

26 July 2017

Joe Cohen

20

1 reference

Europe PubMed Central

26 July 2017

Samuel K Martin

22

1 reference

Europe PubMed Central

26 July 2017

V Ann Stewart

24

1 reference

Europe PubMed Central

26 July 2017

Jeffrey A Lyon

25

1 reference

Europe PubMed Central

26 July 2017

Mark R Withers

27

1 reference

Europe PubMed Central

26 July 2017

language of work or name

0 references

publication date

5 March 2009

1 reference

Europe PubMed Central

26 July 2017

1 reference

Europe PubMed Central

26 July 2017

4

1 reference

Europe PubMed Central

26 July 2017

3

1 reference

Europe PubMed Central

26 July 2017

e4708

1 reference

Europe PubMed Central

26 July 2017

copyright license

Creative Commons CC0 License

5 March 2009

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted, dedicated to the public domain by copyright holder

0 references

describes a project that uses

1 reference

Europe PubMed Central

26 June 2022

https://europepmc.org/article/PMC/PMC2650803

based on heuristic

inferred from PubMed Central ID database lookup

Safety and allele-specific immunogenicity of a malaria vaccine in Malian adults: results of a phase I randomized trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2650803

21 June 2018

Safety and reactogenicity of an MSP-1 malaria vaccine candidate: a randomized phase Ib dose-escalation trial in Kenyan children

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2650803

21 June 2018

Duration of protection with RTS,S/AS02A malaria vaccine in prevention of Plasmodium falciparum disease in Mozambican children: single-blind extended follow-up of a randomised controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2650803

21 June 2018

Characterization of a human reference standard for antibody to Plasmodium falciparum merozoite surface protein 1(42).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2650803

21 June 2018

Towards an RTS,S-based, multi-stage, multi-antigen vaccine against falciparum malaria: progress at the Walter Reed Army Institute of Research.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2650803

21 June 2018

The clinical-grade 42-kilodalton fragment of merozoite surface protein 1 of Plasmodium falciparum strain FVO expressed in Escherichia coli protects Aotus nancymai against challenge with homologous erythrocytic-stage parasites

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2650803

21 June 2018

Efficacy of the RTS,S/AS02A vaccine against Plasmodium falciparum infection and disease in young African children: randomised controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2650803

21 June 2018

The major merozoite surface protein as a malaria vaccine target

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2650803

21 June 2018

The fine specificity, but not the invasion inhibitory activity, of 19-kilodalton merozoite surface protein 1-specific antibodies is associated with resistance to malarial parasitemia in a cross-sectional survey in The Gambia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2650803

21 June 2018

Update on the clinical development of candidate malaria vaccines.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2650803

21 June 2018

Fine specificity of serum antibodies to Plasmodium falciparum merozoite surface protein, PfMSP-1(19), predicts protection from malaria infection and high-density parasitemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2650803

21 June 2018

Immunity to malaria after administration of ultra-low doses of red cells infected with Plasmodium falciparum

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2650803

21 June 2018

A recombinant vaccine expressed in the milk of transgenic mice protects Aotus monkeys from a lethal challenge with Plasmodium falciparum

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2650803

21 June 2018

The economic burden of malaria.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2650803

21 June 2018

Severe falciparum malaria. World Health Organization, Communicable Diseases Cluster

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2650803

21 June 2018

Estimating mortality, morbidity and disability due to malaria among Africa's non-pregnant population.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2650803

21 June 2018

Longitudinal cohort study of the epidemiology of malaria infections in an area of intense malaria transmission II. Descriptive epidemiology of malaria infection and disease among children

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2650803

21 June 2018

Antibodies that inhibit malaria merozoite surface protein-1 processing and erythrocyte invasion are blocked by naturally acquired human antibodies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2650803

21 June 2018

Natural immune response to the C-terminal 19-kilodalton domain of Plasmodium falciparum merozoite surface protein 1.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2650803

21 June 2018

Plasmodium knowlesi: secondary processing of the malaria merozoite surface protein-1

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2650803

21 June 2018

Acquired antibody levels to Plasmodium falciparum merozoite surface antigen 1 in residents of a highly endemic area of Papua New Guinea

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2650803

21 June 2018

A recombinant baculovirus 42-kilodalton C-terminal fragment of Plasmodium falciparum merozoite surface protein 1 protects Aotus monkeys against malaria.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2650803

21 June 2018

Plasmodium falciparum incidence relative to entomologic inoculation rates at a site proposed for testing malaria vaccines in western Kenya

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2650803

21 June 2018

Antibodies inhibit the protease-mediated processing of a malaria merozoite surface protein.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2650803

21 June 2018

Clinical immunity to Plasmodium falciparum malaria is associated with serum antibodies to the 19-kDa C-terminal fragment of the merozoite surface antigen, PfMSP-1.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0004708

21 January 2018

A recombinant blood-stage malaria vaccine reduces Plasmodium falciparum density and exerts selective pressure on parasite populations in a phase 1-2b trial in Papua New Guinea.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0004708

21 January 2018

Development and pre-clinical analysis of a Plasmodium falciparum Merozoite Surface Protein-1(42) malaria vaccine

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0004708

21 January 2018

Pre-clinical evaluation of the malaria vaccine candidate P. falciparum MSP1(42) formulated with novel adjuvants or with alum.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0004708

21 January 2018

Phase I safety and immunogenicity trial of FMP1/AS02A, a Plasmodium falciparum MSP-1 asexual blood stage vaccine

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0004708

21 January 2018

Phase 1 randomized double-blind safety and immunogenicity trial of Plasmodium falciparum malaria merozoite surface protein FMP1 vaccine, adjuvanted with AS02A, in adults in western Kenya

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2650803

31 October 2018

Association of the IgG response to Plasmodium falciparum merozoite protein (C-terminal 19 kD) with clinical immunity to malaria in the Brazilian Amazon region.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2650803

31 October 2018

Assessment of the role of naturally acquired antibody levels to Plasmodium falciparum merozoite surface protein-1 in protecting Papua New Guinean children from malaria morbidity.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2650803

31 October 2018

Identifiers

10.1371/JOURNAL.PONE.0004708

1 reference

Europe PubMed Central

26 July 2017

2009PLoSO...4.4708O

0 references

1 reference

Europe PubMed Central

26 July 2017

1 reference

Europe PubMed Central

26 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33415066&oldid=1871197738"